FiercePharma takes a holiday

FiercePharma won't be published Monday, Jan. 16, as we honor Dr. Martin Luther King Jr. We're hoping you get the opportunity to do the same. Look for our next issue on Tuesday for late-breaking pharma news. - Liz Hollis (email | twitter)

Suggested Articles

After Purdue’s record opioid settlement, more deals could be on the way. But that doesn’t mean all defendants are prepared to go quietly.

Now in their third quarter on the market, Gilead's own Epclusa and Harvoni generics have together grabbed more than 20% of the U.S. hep C market.

Purdue is seeking bankruptcy after inking a $10 billion-plus opioid settlement with thousands of cities and counties, plus two dozen states.